You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 604 Intravenous CMP-001, a CpG-A Toll-like receptor 9 (TLR9) agonist delivered via a virus-like particle, causes tumor regression in syngeneic Hepa1–6 mouse models of hepatocellular carcinoma

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
604 Intravenous CMP-001, a CpG-A Toll-like receptor 9 (TLR9) agonist delivered via a virus-like particle, causes tumor regression in syngeneic Hepa1–6 mouse models of hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020138014
Dec 20206009
Jan 202132011
Feb 20212006
Mar 202142010
Apr 202124010
May 2021306
Jun 2021007
Jul 2021004
Aug 2021004
Sep 2021006
Oct 202140022
Nov 202120023
Dec 202148023
Jan 20222805
Feb 20223405
Mar 20222803
Apr 20223003
May 20223603
Jun 20225407
Jul 20223605
Aug 202286010
Sep 20224001
Oct 20222600
Nov 20223007
Dec 20227203
Jan 20235206
Feb 20232601
Mar 20234003
Apr 20233406
May 202332012
Jun 20231804
Jul 20233606
Aug 20234003
Sep 20232603
Oct 20234607
Nov 20233204
Dec 20233202
Jan 20241802
Feb 20249001
Mar 20248804
Apr 20246401
May 20244500
Jun 20245602
Jul 202411001
Aug 20244602
Sep 20245604
Oct 20244008
Nov 20245407
Dec 20244807
Jan 20254007
Feb 2025602
Mar 2025005
Apr 2025003
May 2025003
Jun 2025005
Total21020328